ISAD Events platform

Welcome to Doha!

Doha 2024
Georg RAJKA — ISAD
hybrid symposium (Doha, QA)
October 24~26, 2024, 08:00 - 19:00

Submission guidelines

We are inviting abstract submissions for the 14th Georg RAJKA symposium of ISAD Society, Doha 2024.

Abstracts for oral and poster presentations will represent the core of the scientific program at this meeting. Abstracts pertaining to human atopic dermatitis and related fields including animal models are appropriate.

Important dates (2024)

Submission opens Friday, May. 24th
Deadline for Submission
inclusive, 23:59 Doha/AST time
Monday, Jul. 15th
Notice of Adjudication Wednesday, Jul. 31st
Deadline for registration of presenting authors Sunday, Aug. 18th
File submission site opens Monday, Aug. 5th
Deadline for oral session presenters to select an in-person or virtual presentation
Oral poster presentation: in-person only
Sunday, Oct. 6th
File submission site closes Sunday, Oct. 27th
Understand day included, Doha/AST time (UTC+03:00).

Abstract submission process

Abstracts will be accepted via this online submission system only (email submissions will not be accepted).

One (submitter) can submit one or many abstracts on our platform with its personal account, and non-authors (agents) can submit on behalf of an author (who needs an account too for the follow up). The submitter warrants having the full power, authority and capacity to submit the abstract and agree to these terms and conditions.

An acknowledgement of receipt by email of each submission will be sent automatically to the submitter’s mailbox upon completion of the online submission, and to the presenting/corresponding author(s).

  • submitters may modify their submission(s) until the deadline: late or incomplete submissions will not be accepted.
  • The official language is English only.
  • Read carefully the all agreements to accept at the end of the submission form (condition of acceptance, publication authorization, statement of responsibility, cf. platform).
  • Encore presentations are not accepted, still, it is possible to submit one with updated study/data and a detailed justification adressed to the reviewers (tick the appropriate checkbox).

Abstract format

Abstract submissions will be reviewed for presentations in one of three formats:

  • 1. oral presentation in scientific sessions (in-person/virtual)
  • 2. oral poster presentation (in-person only, 5 minutes during the breaks on one of the screens)
  • 3. poster with no oral presentation (available only on displays and online for attendees)

Every effort will be made to accommodate requests based on considerations regarding space availability and conference program themes: by default and if not refused, all abstracts are subjects to be accepted as posters with no oral presentation.

If an abstract is not selected for an oral presentation, it is possible to indicate in the online submission form if one will consider an oral poster presentation in the event (a few selected posters will be scheduled for short oral poster presentations during the breaks).

Abstract topics

All abstracts submitted must address one of the conference topics for inclusion in the program. The list of available topics when submitting an abstract is:

  • Pathophysiology of AD
  • Immunity dysregulation
  • Primary Prevention and Comorbidities
  • Pruritus and AD
  • Quality of Life & Comorbidities, Epidemiology
  • New Technologies and AD
  • Topical treatment and phototherapy
  • New Targeted and Systemic Therapies for AD
  • Future treatments of AD
  • Initiatives at the international level — poster only
  • Patient-centered medicine — poster only
  • Other — poster only

Each abstract content must be described accurately with 2 or 3 keywords from the provided list in the form.

All selected abstracts will be reproduced exactly as submitted and substitutions will not be permitted. They must be proofread very carefully before submitting.

Abstract writing guide

Title
Use a concise descriptive title that indicates the content of the abstract.
Please minimize the use of abbreviations in the title.
Commercial trade names for drugs, devices, products and services may NOT be used in the title.
Authors
Information for each author (no limit about the number of authors) must be provided as requested in the form: department, institution, city, and country. Do not include degrees or titles.
Contacts
The submitter is the only corresponding contact (notifications are sent to the email of the account).
Presenting author has to be indicated in the proper section of the online form.
Abstract body
  • Limit your abstracts to no more than 1600 characters (count does not include spaces).
  • Do not include tables/charts, graphics or images in your abstract.
  • Drugs, devices, products, and services should be identified by generic name only within the abstract. Refer to generic names rather than brand names.
  • Only common and standard abbreviations may be used without definition.

The body of the abstract should be formatted with the following five sections:

  • 1. Introduction / Background (mandatory)
  • 2. Objective (optional for clinical case)
  • 3. Method (optional for clinical case)
  • 4. Results (optional for clinical case)
  • 5. Conclusions (mandatory)

Late-breaking abstracts

Currently, there is no late-breaking abstracts submission period planned.

Abstract adjudication

A “blind” selection process will be used: abstracts will be peer-reviewed and ranked by ISAD Scientific Committee members. Notice of abstract adjudication will be provided on Wednesday, Jul. 31st. All correspondences will be addressed to the submitting contact by email only, unless otherwise requested.

Deadline for registration of presenting authors

Presenting authors not registered by Sunday, Aug. 18th will forfeit both their invitation to present and have their abstract included in the conference platform. Changing presenters to another author is allowed prior to this date but a non-author can not present on behalf of the authors. Changes of presenting authors must be made in writing to support@isad.org

Presentations

Oral presentations in scientific sessions

Oral presentations will take place live in Doha, Qatar, in real time during scheduled sessions based on local time (AST, visit the time converter). As this will be a hybrid conference (in-person and online), accepted oral presenters will have the choice to present their oral presentation in-person in Doha or virtually via their computer using Internet and Zoom software. Virtual presenters must have access to a computer with camera and audio and a wired internet connection or strong Wi-Fi. The time zone of all presentations will be Arabia Standard Time Time (AST).

Oral presenters must confirm if they will attend in-person or virtually by Sunday, Oct. 6th.

Oral posters presentations

Same conditions as Oral presentations in scientific sessions, but:

  • no virtual presentation is possible, the presenter must be there in-person during the attributed slot
  • duration: 5 minutes / 8 slides maximum (instructions will be available with the notification of adjudication - info: QR codes are accepted)
Poster with no oral presentation (on screens only)

As every presentation, all posters will be available online via the virtual conference platform.

File submission

Submission guidelines will be sent with the notification of adjudication, The online file submission site will open on Monday, Aug. 5th, and close on Sunday, Oct. 27th. Late submissions or changes after the closing date will not be accepted.

➜ Check the guidelines

Embargo

Submitted abstracts are considered confidential by ISAD Society until publicly presented and/or published in connection with the symposium. Prior to such presentation or publishing, the author(s), research sponsors, or proprietors of the copyright in the abstract(s) may not make the information public or use the information for trading purposes without obtaining prior written permission from ISAD Society.

Copyrights

All copyrights remain to the author(s).

Privacy policy

Submitters agree that ISAD Society will process their personal data, including storing or transferring such data outside of their country of residence, in order to process transactions related to the publishing and/or presentation of their abstract. Submitters also confirm that same permission has been obtained from all other contributors/authors in accordance with these terms and conditions.

Website Newsletter Opt-in

Check our FAQ or contact support@isad.org for assistance